Traitement pharmacologique de l'état de mal réfractaire [Drug treatment of refractory status epilepticus]

Details

Serval ID
serval:BIB_4CDC0F9A7B51
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Traitement pharmacologique de l'état de mal réfractaire [Drug treatment of refractory status epilepticus]
Journal
Revue Neurologique
Author(s)
Rossetti A.O., Santoli F.
ISSN
0035-3787
Publication state
Published
Issued date
2009
Peer-reviewed
Oui
Volume
165
Number
4
Pages
373-379
Language
french
Abstract
Status epilepticus (SE) refractory to benzodiazepines and other antiepileptic agents is managed with intravenous anesthetic compounds, such as thiopental, propofol or midazolam. These drugs display quite different pharmacodynamic and pharmacokinetic properties, but have not been prospectively compared to date. Their use is clearly advocated for the treatment of generalized convulsive SE, whereas partial-complex, or absence SE are generally managed less aggressively, in consideration of their better prognosis. The most important aspect seems to be related to the correct use of these anesthetics in the right context, rather than the choice of one specific compound. An electroencephalographic burst-suppression should be targeted for about 24hour, before progressive weaning of the dosage under EEG monitoring. If this approach proves unsuccessful, the use of other drugs, including inhalational anesthetics, has been described.
Pubmed
Web of science
Create date
13/05/2009 17:10
Last modification date
20/08/2019 15:01
Usage data